A recent report published by The Business Research Company on Antibody Drug Conjugates Market provides in-depth analysis of segments and sub-segments in the global as well as regional.
The global antibody drug conjugates market was valued at about $1.89 billion in 2018 and is expected to grow to $4.98 billion at a CAGR of 27.4% through 2022.
The antibody-drug conjugates (ADCs) market consists of sales of antibody-drug conjugates (ADCs). Antibody-drug conjugates (ADCs) are complex engineered therapeutics consisting of monoclonal antibodies, directed toward tumor-associated antigens, to which highly potent cytotoxic agents are attached using chemical linkers.
Major players in the market are Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics, Inc., Oxford BioTherapeutics
North America was the largest region in the antibody drug conjugates market in 2018. This region is expected to remain the largest during the next five years. The antibody drug conjugates market in the same region is forecasted to register the highest CAGR during 2018-2023.
The antibody drug conjugates market is being driven by rising incidences of cancer globally. The major causes for most cancers include obesity, smoking, alcohol, improper eating habits. According to the World Health Organization, cancer is responsible for an estimated 9.6 million deaths in 2018. The Cancer Research UK predicts that there will be 27.5 million new cases of cancer each year by 2040.
Request a Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp
Few Points From Table Of Content
- Executive Summary
- Antibody Drug Conjugates Market Characteristics
- Antibody Drug Conjugates Market Size And Growth
- Antibody Drug Conjugates Market Segmentation
- Antibody Drug Conjugates Market Regional And Country Analysis
- Asia-Pacific Antibody Drug Conjugates Market
- China Antibody Drug Conjugates Market
- India Antibody Drug Conjugates Market
- Japan Antibody Drug Conjugates Market
- Australia Antibody Drug Conjugates Market
- Indonesia Antibody Drug Conjugates Market
- South Korea Antibody Drug Conjugates Market
View Related Report: https://www.thebusinessresearchcompany.com/report/biologics-market
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company